Theranos Investor Conference Presentation Deck slide image

Theranos Investor Conference Presentation Deck

Lipids on miniLab Correlate to Comparator Method for Venous Plasma miniLab (mg/dL) miniLab (mg/dL) 350 300- 250- 200- 150- 100 250- 200 150 100- 50 y = 0.97 x + 3.74 = 0.99 n = 103 100 150 200 250 300 350 Siemens ADVIA 1800 (mg/dL) Total Cholesterol Median bias = -0.9 % ATE = + 9% Points within ATE = 100% y = 0.98 x + 4.01 2=0.95 n=103 LDL Cholesterol Median bias = 2.4% ATE = ± 12% Points within ATE = 92% 50 100 150 200 250 Siemens ADVIA 1800 (mg/dL) This technology has not been cleared or approved by the FDA and is not for sale in the United States. miniLab (mg/dL) 800- 600- 400- 200 0 0 140- 120- miniLab 100- (mg/dL) 80- 60- 40- 20- y= 1.03 x 1.58 r² = 0.99 n = 103 200 400 600 800 Siemens ADVIA 1800 (mg/dL) y = 1.03 x + 3.09 ²=0.95 n-103 Legend: Unity (y = x) - Allowable total error 20 NCEP (Clin Chem 1988;34:193-201) NCEP (Clin Chem 1997;43:2164-2168) Triglycerides Median bias = 0.6% ATE = ± 15% Points within ATE = 98% HDL Cholesterol Median bias = 9% ATE = ± 13% Points within ATE = 76% 40 60 80 100 140 Siemens ADVIA 1800 (mg/dL) theranos 28
View entire presentation